Ignite Creation Date:
2025-12-24 @ 7:43 PM
Ignite Modification Date:
2026-01-16 @ 2:36 PM
Study NCT ID:
NCT00952003
Status:
COMPLETED
Last Update Posted:
2020-11-30
First Post:
2009-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients
Sponsor:
Arbeitsgemeinschaft medikamentoese Tumortherapie
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AGMT GASTRIC-3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None